BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Magnetic Resonance (MR) guided radiotherapy treatment systems including associated options, upgrades, accessories, hardware, software and building works. Note that all applicants must be able to supply a MR radiotherapy treatment system in order to put forward a tender and in order to be successfully-awarded to any future Framework Agreement. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 16 000 000 GBP in the first year of the Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options) is 64 000 000 GBP.
No supplier information available.